Search

Your search keyword '"Fuchs, Bryan C."' showing total 417 results

Search Constraints

Start Over You searched for: Author "Fuchs, Bryan C." Remove constraint Author: "Fuchs, Bryan C."
417 results on '"Fuchs, Bryan C."'

Search Results

2. Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice

3. Molecular MR Imaging of Renal Fibrogenesis in Mice

4. Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver

6. A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis

8. Precision-Cut Liver Slices as anex vivomodel to evaluate antifibrotic therapies for liver fibrosis and cirrhosis

10. A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery

14. Cell type-specific pharmacological kinase inhibition for cancer chemoprevention

15. Molecular imaging of fibrosis: recent advances and future directions

17. pH dependence of a GPR4 selective antagonist hampers its therapeutic potential

21. Figure from Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI

22. Supplementary Legends, Table from Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI

26. A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity

28. Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram

29. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation

30. Peroxidasin deficiency re-programs macrophages toward pro-fibrolysis function and promotes collagen resolution in liver

32. Abstract 255: Peroxidasin deficiency recruits pro-healing macrophages into the liver and inhibits NAFLD progression to HCC

44. Reply

45. Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram.

49. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma

50. A Blood-Based Prognostic Liver Secretome Signature and Long-Term Hepatocellular Carcinoma Risk in Advanced Liver Fibrosis

Catalog

Books, media, physical & digital resources